92 related articles for article (PubMed ID: 1837782)
21. [Hormonal pregnancy parameters in the serum following surgery for extrauterine pregnancy].
Riss P; Reinthaller A; Deutinger J; Radivojevic K; Bieglmayer C
Z Geburtshilfe Perinatol; 1987; 191(4):146-9. PubMed ID: 2446439
[TBL] [Abstract][Full Text] [Related]
22. Omental trophoblastic implants after surgical management of ectopic pregnancy.
Bucella D; Buxant F; Anaf V; Simon P; Fayt I; Noël JC
Arch Gynecol Obstet; 2009 Jul; 280(1):115-7. PubMed ID: 19039599
[TBL] [Abstract][Full Text] [Related]
23. [The clinical picture of endoscopically treated extrauterine pregnancy. Postoperative follow-up of 677 endoscopically operated extrauterine pregnancies 1983-1993].
Zöckler R; Dressler F; Raatz D; Börner P
Geburtshilfe Frauenheilkd; 1995 Jul; 55(7):365-8. PubMed ID: 7557200
[TBL] [Abstract][Full Text] [Related]
24. The treatment of unruptured tubal pregnancy with intratubal methotrexate injection under laparoscopic control.
Kojima E; Abe Y; Morita M; Ito M; Hirakawa S; Momose K
Obstet Gynecol; 1990 Apr; 75(4):723-5. PubMed ID: 2138266
[TBL] [Abstract][Full Text] [Related]
25. [Laparoscopic management of extrauterine pregnancy].
Borsellino G; Danile G
Minerva Ginecol; 1995 Nov; 47(11):471-6. PubMed ID: 8820391
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum hCG level and intraoperative failure of laparoscopic linear salpingostomy for ectopic pregnancy.
Mol BW; Dijkhuizen FP
Obstet Gynecol; 1999 Feb; 93(2):319-20. PubMed ID: 9932578
[No Abstract] [Full Text] [Related]
27. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases.
Stovall TG; Ling FW; Gray LA; Carson SA; Buster JE
Obstet Gynecol; 1991 May; 77(5):749-53. PubMed ID: 2014090
[TBL] [Abstract][Full Text] [Related]
28. [Laparoscopic management of extrauterine pregnancy by salpingotomy].
Inovay J; Szabó I; Csabay L; Szendei G; Papp Z
Orv Hetil; 1994 Feb; 135(7):357-60. PubMed ID: 8127588
[TBL] [Abstract][Full Text] [Related]
29. Time length of negativization of hCG serum values after either surgical or medical treatment of ectopic pregnancy.
Colacurci N; De Franciscis P; Zarcone R; Fortunato N; Passaro M; Mollo A; Russo G
Panminerva Med; 1998 Sep; 40(3):223-5. PubMed ID: 9785922
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for persistent trophoblastic activity after surgery for ectopic pregnancy.
Nathorst-Böös J; Rafik Hamad R
Acta Obstet Gynecol Scand; 2004 May; 83(5):471-5. PubMed ID: 15059161
[TBL] [Abstract][Full Text] [Related]
31. [Intrauterine pregnancy after conservative treatment of ectopic pregnancy with contralateral removal of the adnexa].
Alge A; Huter O; Anderl P
Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):421-2. PubMed ID: 7926577
[TBL] [Abstract][Full Text] [Related]
32. [Risks of expectant management of extrauterine pregnancies with low HCG titers and absent clinical symptoms].
Küpker W; Bauer O; Löning M; Felberbaum R; Diedrich K
Zentralbl Gynakol; 1996; 118(11):622-4. PubMed ID: 9082696
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic salpingocentesis using methotrexate in combination with oral mifepristone for successful treatment of interstitial pregnancy: a case report.
Narang L; Kalu G
Fertil Steril; 2009 Dec; 92(6):2038.e5-7. PubMed ID: 19819446
[TBL] [Abstract][Full Text] [Related]
34. [Tubal rupture after prostaglandin instillation despite decreasing beta-HCG values].
Tews G; Arzt W; Tulzer G
Wien Klin Wochenschr; 1992; 104(2):45-6. PubMed ID: 1376949
[TBL] [Abstract][Full Text] [Related]
35. Treatment of tubal pregnancy in the netherlands: an economic comparison of systemic methotrexate administration and laparoscopic salpingostomy.
Mol BW; Hajenius PJ; Engelsbel S; Ankum WM; Hemrika DJ; Van der Veen F; Bossuyt PM
Am J Obstet Gynecol; 1999 Oct; 181(4):945-51. PubMed ID: 10521759
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of tubal pregnancy with methotrexate].
Chryssikopulos A; Grigoriu O; Vitoratos N
Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):753-4. PubMed ID: 2529166
[TBL] [Abstract][Full Text] [Related]
37. Persistent ectopic pregnancy after laparoscopic salpingotomy: a manageable complication to preserve reproductive tubal function.
Suzuki T; Izumi S; Nakamura E; Goya K; Kika G; Sugiyama T; Cai LY; Murano T
Tokai J Exp Clin Med; 2009 Sep; 34(3):112-6. PubMed ID: 21319010
[TBL] [Abstract][Full Text] [Related]
38. [Laparoscopic treatment of tubal pregnancy using local administration of prostaglandin F2 alpha].
Ventruba P; Cupr Z
Cesk Gynekol; 1992 Feb; 57(1):28-32. PubMed ID: 1385760
[TBL] [Abstract][Full Text] [Related]
39. Persistent tubal pregnancy presenting with delayed hemorrhage from a second implantation of trophoblast on the ovary: a case report.
Robinson RD; Ginsburg ES
J Reprod Med; 2004 Aug; 49(8):693-5. PubMed ID: 15457862
[TBL] [Abstract][Full Text] [Related]
40. Extratubal secondary trophoblastic implants: clinicopathologic correlation and review of the literature.
Doss BJ; Jacques SM; Qureshi F; Ramirez NC; Lawrence WD
Hum Pathol; 1998 Feb; 29(2):184-7. PubMed ID: 9490280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
